US 12138263
Pyrazolo[3,4-b]pyrazine SHP2 phosphatase inhibitors and methods of use thereof
granted A61KA61K31/4985A61K38/465
Quick answer
US patent 12138263 (Pyrazolo[3,4-b]pyrazine SHP2 phosphatase inhibitors and methods of use thereof) held by Relay Therapeutics, Inc. expires Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Relay Therapeutics, Inc.
- Grant date
- Tue Nov 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/4985, A61K38/465, A61K45/06, A61K47/64